On Feb 11, 2026, VERU reported earnings of -0.26 USD per share (EPS) for Q1 26, beating the estimate of -0.47 USD, resulting in a 45.77% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.43% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 4 analysts forecast an EPS of -0.29 USD, with revenue projected to reach -- USD, implying an increase of 11.54% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Mar 17, 2026 For Q3 26
Estimate
-$0.60
Actual
-$0.61
Surprise
-0.39%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
FAQ
What were Veru Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Veru Inc. reported EPS of -$0.26, beating estimates by 45.77%, and revenue of $0.00, 0% as expectations.
How did the market react to Veru Inc.'s Q1 2026 earnings?
The stock price moved down -0.43%, changed from $2.31 before the earnings release to $2.30 the day after.
When is Veru Inc. expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Veru Inc.'s next earnings report?
Based on 4
analysts, Veru Inc. is expected to report EPS of -$0.29 and revenue of -- for Q2 2026.